Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
Key Highlights
- ➤Shareholders approved one-for-five consolidation of ordinary and preferred shares.
- ➤Authorized capital rises to US$105,000 and 210,000,000 shares.
- ➤Changes take effect at market open November 9, 2026.
- ➤Ordinary shares outstanding will fall from 158,400,314 to approximately 31,680,063.
- ➤Warrants’ share amounts decrease and exercise prices increase proportionally.
KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its shareholders approved, in accordance with Cayman Islands law, all of the proposals submitted at the Company’s Extraordinary General Meeting held on October 30, 2026 (the “EGM”).
At the EGM, the Alps shareholders approved (i) a share consolidation of the Company’s ordinary shares and its preferred shares at a ratio of one-for-five, whereby every five shares consolidated into one (the “Share Consolidation”); (ii) an increase in the Company’s authorized share capital (the “Share Capital Increase”); and (iii) the adoption of the Second Amended and Restated Memorandum and Articles of Association.
Get started
Create a free account to read the full story.